Phase II Clinical Trial on the Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients With Homologous Recombination Deficiency
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2017
At a glance
- Drugs Carboplatin (Primary) ; Eribulin (Primary) ; Veliparib (Primary)
- Indications Breast cancer; Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Jun 2017 Planned initiation date changed from 31 May 2017 to 31 Jul 2017.
- 13 Apr 2017 Planned initiation date changed from 31 Mar 2017 to 31 May 2017.
- 03 Feb 2017 New trial record